Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,616.50
Bid: 1,618.00
Ask: 1,618.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,607.50
High: 1,620.00
Low: 1,594.00
Prev. Close: 1,612.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 13th Oct 2014 09:32

Amino Technologies: Northland Capital upgrades to buy with a target price of 100p.Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p.Associated British Foods: Societe Generale upgrades to buy with a target price of 2950p.AstraZeneca: Jefferies raises target price from 4500p to 5000p upgrading to buy.Betfair Group: Numis reduces target price from 1250p to 940p downgrading to reduce.Bodycote: Investec cuts target price from 775p to 750p and stays with its buy recommendation.Brammer: Investec cuts target price from 435p to 400p, while keeping a buy recommendation.Brown (N) Group: N+1 Singer reduces target price from 585p to 390p, while staying with its buy recommendation. Jefferies cuts target price from 540p to 406p and reiterates a buy recommendation.BTG: Investec raises target price from 728p to 832p staying with its buy recommendation.bwin.party: Numis cuts target price from 200p to 180p and keeps a buy recommendation.Coca-Cola HBC: Credit Suisse reduces target price from 1500p to 1400p, while maintaining its neutral rating.Dialight: Investec reduces target price from 910p to 850p downgrading to sell.Domino Printing: Investec cuts target price from 650p to 615p keeping an add rating.Eagle Eye: Panmure Gordon initiates with a target price of 229p and a buy recommendation.Fenner: Investec cuts target price from 320p to 270p and retains a sell recommendation.Ferrexpo: Cantor Fitzgerald reduces target price from 250p to 120p maintaining a buy recommendation.GKN: Investec cuts target price from 380p to 330p, while upgrading from add to buy.GlaxoSmithKline: Jefferies ups target price from 1385p to 1400p and retains a hold recommendation.Glencore: Canaccord Genuity initiates with a target price of 400p and a buy recommendation.Halma: Investec lowers target price from 635p to 630p and maintains a buy recommendation.Hellermann Tyton: Investec lowers target price from 305p to 300p and retains a hold recommendation.IMI: Investec reduces target price from 1560p to 1425p and keeps a buy recommendation.IMImobile: WH Ireland ups target price from 175p to 187p and retains a buy recommendation.Jupiter Fund Management: JP Morgan cuts target price from 465p to 400p staying with an overweight rating. Espirito Santo cuts target price from 489p to 469p leaving its buy recommendation unaltered.Ladbrokers: Numis reduces target price from 150p to 100p downgrading to reduce.Laird: Investec lowers target price from 260p to 250p leaving its sell recommendation unchanged.Melrose: Investec shifts target price from 332p to 335p and keeps a buy recommendation.Molins: Panmure Gordon reduces target price from 250p to 165p and stays with its buy recommendation.Morgan Advanced Materials: Investec lowers target price from 345p to 335p reiterating its buy recommendation.Oxford Instruments: Investec reduces target price from 1520p to 1405p and reiterates a buy recommendation.Paragon Group: JP Morgan ups target price from 396p to 420p and leaves its overweight rating unchanged.Playtech: Numis cuts target price from 700p to 665p and reiterates a hold recommendation.Renishaw: Investec reduces target price from 1900p to 1775p keeping a buy recommendation.Rotork: Investec reduces target price from 2840p to 2610p retaining its add rating.Smith (DS): Investec cuts target price from 380p to 350p and stays with its buy recommendation.Smith & Nephew: Investec reduces target price from 1100p to 1023p and downgrades from add to hold.Smith (WH): Canaccord Genuity initiates with a target price of 1225p and a buy recommendation.Spectris: Investec reduces target price from 2580p to 2380p and maintains a buy recommendation.Spirax-Sarco: Investec reduces target price from 2920p to 2810p and stays with its add rating.TSB: Investec shifts target price from 290p to 295p upgrading from hold to buy.Vedanta Resources: Canaccord Genuity initiates with a target price of 1020p and a hold recommendation. JP Morgan lowers target price from 1140p to 1130p and retains its neutral rating.Vesuvius: Investec cuts target price from 485p to 450p and reiterates an add rating.Vitec Group: Investec cuts target price from 790p to 740p maintaining a buy recommendation.Weir Group: Investec raises target price from 2400p to 2525p, but still recommends selling.William Hill: Numis reduces target price from 500p to 400p downgrading to add.888 Holdings: Numis cuts target price from 220p to 175p and keeps a buy recommendation.32Red: Numis lowers target price from 100p to 80p, while retaining its buy recommendation.
More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.